- Home
- EVGN
EVGN
Evogene Ltd
as 11-20-2024 4:00pm EST
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.
| Founded: | 1999 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 9.7M | IPO Year: | N/A |
| Target Price: | $12.00 | AVG Volume (30 days): | 800.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.95 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.56 - $10.40 | Next Earning Date: | 11-21-2024 |
| Revenue: | $9,449,000 | Revenue Growth: | 290.29% |
| Revenue Growth (this year): | 173.12% | Revenue Growth (next year): | 33.10% |
Latest Evogene Ltd News
EVGN Breaking Stock News: Dive into EVGN Ticker-Specific Updates for Smart Investing
PR Newswire
2 days ago
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results
PR Newswire
9 days ago
Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials
PR Newswire
14 days ago
Evogene Schedules Third Quarter 2024 Financial Results Release
MT Newswires
21 days ago
Evogene, Google Collaborate to Build AI Model for Small Molecule Design
PR Newswire
21 days ago
Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design
PR Newswire
23 days ago
Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya
PR Newswire
a month ago
Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology
PR Newswire
2 months ago
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals
Compare EVGN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EVGN Evogene Ltd - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.